Stanford University
Showing 131-140 of 205 Results
-
Alma Rodriguez
Ph.D. Student in Education, admitted Autumn 2024
BioAlma Rodriguez is a third-year Ph.D. candidate at Stanford’s Graduate School of Education, specializing in Sociology of Education under the supervision of Dr. Anthony Lising Antonio. Alma is a DACA (Deferred Action for Childhood Arrivals) recipient who earned her Bachelor of Arts in Sociology with highest honors from the University of California, Berkeley. Her research interest focuses on the undocumented student population. During her undergrad, Alma completed her senior honor’s thesis under the supervision of the Sociology department at UC Berkeley.
At Stanford University, Alma's research sits at the intersection of social movements, undocumented student activism, and higher education. Her work examines how undocumented students in California engage in hidden forms of activism and strategic adaptation, navigating visibility, risk, and resistance in response to shifting political climates. Drawing on non-visible, everyday activism and social movement scholarship, Alma explores how undocumented students resist, and continue to exercise their political voice when visibility imposes existential risks.
A qualitative scholar by training, Alma conducts ethnographic fieldwork inside Dream Centers, centering the lived experiences and political agency of undocumented students as her primary unit of analysis. -
Carlos Jose Rodriguez Santiago
Ph.D. Student in Chemical Engineering, admitted Autumn 2022
BioCarlos Rodriguez Santiago is a Chemical Engineering PhD candidate working in the lab of Dr. Judith Shizuru to develop protein therapeutics that will facilitate hematopoietic stem cell transplantation without the need for chemotherapy or radiation. His PhD thesis work is at the intersection of immunology, oncology, and protein engineering. Carlos is also a Sarafan CheM-H Lipshultz Graduate Fellow participating in the Chemistry/Biology Interface (CBI) Predoctoral training program which aims to cultivate interactions and thinking across disciplinary lines to enable innovations that improve human health.
Prior to his PhD work, Carlos helped found the Protein Engineering Knowledge Center (PEKC) at Stanfords Innovative Medicines Accelerator (IMA). There he collaborated with researchers to discover and engineer antibodies against therapeutically relevant targets. Several antibodies discovered by Carlos have officially been licensed out for further therapeutic development.
